(Q48253543)

10 February 2018

title

Co-occurrence of MYC amplification and TP53 mutations in human cancer. (English)

1 reference

10 February 2018

author

Peter Ulz

series ordinal

1

1 reference

10 February 2018

Ellen Heitzer

series ordinal

2

1 reference

10 February 2018

Michael R. Speicher

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 2016

1 reference

10 February 2018

published in

Nature Genetics

1 reference

10 February 2018

volume

48

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

104-106

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1038/ng.3468

exact match

0 references

cites work

The landscape of somatic copy-number alteration across human cancers

1 reference

21 January 2018

Cancer genome landscapes

1 reference

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

21 January 2018

1 reference

Mutual exclusivity analysis identifies oncogenic network modules

21 January 2018

1 reference

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

21 January 2018

1 reference

TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis

21 January 2018

1 reference

Mediation of c-Myc-induced apoptosis by p53.

21 January 2018

1 reference

Taming of the beast: shaping Myc-dependent amplification

21 January 2018

1 reference

MYC on the path to cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1038/NG.3468

1 reference

10 February 2018

PubMed ID

26813759

1 reference

10 February 2018